Company Overview of Theron Pharmaceuticals Inc.
Theron Pharmaceuticals Inc., a biotechnology company, develops long acting M3 muscarinic antagonist (LAMA) products for the treatment of chronic respiratory diseases. Its lead development candidate includes TRN-157, a preclinical development therapy that focuses on treating chronic obstructive pulmonary disease and severe asthma. The company was founded in 2008 and is based in Sunnyvale, California.
365 San Aleso Avenue
Sunnyvale, CA 94085
Founded in 2008
Key Executives for Theron Pharmaceuticals Inc.
Similar Private Companies By Industry
|EarlyCell, Inc.||United States|
|EMD Biosciences, Inc.||United States|
|Hapten Sciences Development, LLC||United States|
|BASF Plant Science L.P.||United States|
|DynPort Vaccine Company LLC||United States|
Recent Private Companies Transactions
July 24, 2015
To contact Theron Pharmaceuticals Inc., please visit www.theronpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.